Glyphic Biotechnologies
Next Generation Protein Sequencing
Berkeley, United States · Founded 2021 · $42.5M raised
- Headquarters
- Berkeley, California
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- glyphic.bio
- Total Funding
- $42.5M
- Last Round
- $2.9M Series ASep 2025
- Rounds
- 4
About
Founded in 2021 and headquartered in Berkeley, California, Glyphic Biotechnologies exists to fundamentally rewrite the rules of proteomics. The company is developing Protein Sequencing by Expansion (ProSE™), the first truly de novo high-throughput proteome sequencing technology capable of discriminating all 20 amino acids and post-translational modifications with single-molecule sensitivity. Glyphic's platform leverages spatial expansion of amino acids to enable massively parallel proteome sequencing, unlocking critical first-in-class therapies and deeper insights into biology.
Summary
Glyphic Biotechnologies is a Biotech company based in Berkeley, United States, founded in 2021. It has raised $42.5M in total across 4 rounds, most recently a $2.9M Series A round in Sep 2025. Investors include OMX Ventures and Osage University Partners.
Tech & App Stack
20 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Long-read DNA sequencing company providing advanced systems for complete and accurate genome, tra...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.